Mercodia AB

Mercodia is a Swedish life science company and the premier bioanalytical CRO specialized in metabolic diseases. For over 35 years, we have provided proprietary immunoassay solutions, along with scientific, bioanalytical, and regulatory expertise, to accelerate drug development programs targeting diabetes, obesity, and related cardiorenal-metabolic conditions.

We understand the unique complexities of these diseases because they are the foundation of our expertise. This deep focus enables us to integrate seamlessly as your dedicated scientific extension, helping you achieve your development goals more efficiently.

Our offering combines three core business areas: gold-standard immunoassays, expert bioanalytical services, and scalable contract manufacturing. All in one streamlined solution. From our GLP-compliant laboratories in Europe and the US, we support preclinical through clinical phases with reliable, actionable data.

Vision | Our vision is to improve human health through the use of our products and services by scientists worldwide. 

Mission | Mercodia develops tools to advance life science and pharmaceutical research. We are committed to delivering products and services with the highest reliability and accuracy, becoming a trusted and valued partner to customers worldwide.